AAV 2G-UNic® Vector Technology
Your path to increased transgene expression and viral vector titers for your gene therapy
Dive into the forefront of adeno-associated virus (AAV) transgene expression enhancement with our breakthrough AAV-2G UNic® vector technology. By seamlessly integrating this advanced technology with your existing vector system, you unlock unparalleled gene expression enhancements for your payload.
Embark on a journey of innovation and discovery as we redefine the landscape of viral vector production. Experience the transformative power of our solutions, offering not only remarkable performance but also cost-effectiveness.
Coming Soon - AAV-2G UNic® for increased AAV titers
Similar to our LV-2G UNic® vector technology we have promising results increasing AAV titers to support gene therapy manufacturing requirements.
- Boost Capacity: Enables you to increase manufacturing capacity without the need to change process or equipment
- Cost Effective: Reduce manufacturing costs significantly without capital costs often associated with scale-up
- Early Access Program Launched: Available for co-development and facilitating easy integration into your projects.
Join our AAV-2G UNic® Early Access Program
Unlock the Potential:
- Gain exclusive access to ProteoNic’s cutting-edge AAV-2G UNic® vector technology to boost your transgene expression or AAV vector titers.
- Seamlessly integrate this advanced vector technology into your current workflow.
- Elevate your therapy efficacy or improve your manufacturing capacity with clinically proven technology, available for integration into your workflow today.
Limited Partner Availability:
Our Early Access Program has limited partner slots available. Contact us now to secure your spot and learn more about this groundbreaking technology.
Unlock the Power of AAV-2G UNic® Vector Technology
Enhanced payload expression:
Benefit from increased payload expression levels achieved through a unique blend of methodologies:- Dual Promoter: Harness the patented technology of two promoters ingeniously merged to amplify transcription.
- More protein per mRNA: Enhance payload expression through significant boosts in mRNA stability, transport and translation